More News

23 Mar 2020 Bayer and Curadev sign research collaboration and license agreement to develop novel STING antagonists across indications
18 Mar 2020 Immatics Announces Business Combination with Arya Sciences Acquisition Corp., Creating a Publicly Listed Leader in TCR-based Immunotherapies
18 Mar 2020 RIBOMIC Enters License Agreement with AJU Pharma for RBM-007 in Age-related Macular Degeneration
18 Mar 2020 HORAMA Signs Exclusive License Agreement with Leiden University Medical Center Targeting CRB1 Gene Mutations to Treat Inherited Retinal Dystrophies
17 Mar 2020 Eureka Therapeutics Completes $45 Million Series E Financing and Enters into Strategic Collaboration with Lyell Immunopharma
16 Mar 2020 Tetraphase Pharmaceuticals and AcelRx Pharmaceuticals Enter into Definitive Merger Agreement
16 Mar 2020 BioNTech and Fosun Pharma form COVID-19 vaccine strategic alliance in China
15 Mar 2020 Nurix Therapeutics Closes $120 Million Financing to Advance Targeted Protein Modulation Drug Pipeline
11 Mar 2020 Vir Biotechnology Announces Research Collaboration with the National Institutes of Health Vaccine Research Center on Antibodies Against Coronaviruses
10 Mar 2020 Bridge Biotherapeutics Enters AI-based Research Collaboration with Atomwise to Expand Pellino Inhibitor Pipeline
09 Mar 2020 MolMed signs a multi-year agreement and announces the beginning of a new collaboration in the field of T cell therapies
09 Mar 2020 Abpro Forms Strategic Partnership to Advance Two Bispecific Antibody Candidates in Asian Markets
09 Mar 2020 Zydus and XOMA Announce IL-2-Based Immuno-Oncology Therapy Licensing Agreement
06 Mar 2020 Orionis Biosciences Debuts with Major Pharmaceutical Collaboration to Tackle Industry’s Most Challenging Protein Targets
04 Mar 2020 Voluntis and Bristol-Myers Squibb to Co-Develop Digital Therapeutics for Oncology
04 Mar 2020 Vir and Alnylam Expand Collaboration to Advance RNAi Therapeutics for the Treatment of Coronavirus Infection, Including COVID-19
04 Mar 2020 Iktos and SRI International Announce Collaboration to Combine Artificial Intelligence and Novel Automated Discovery Platform for Accelerated Development of New Anti-Viral Therapies
02 Mar 2020 Gilead to Acquire Forty Seven for $4.9 Billion
29 Feb 2020 Boehringer Ingelheim Enters Discovery Stage Collaboration with Trutino Biosciences to Grow Its Cancer Immunology Portfolio with Novel Cytokine Platform
29 Feb 2020 Biogen and Sangamo Announce Global Collaboration to Develop Gene Regulation Therapies for Alzheimer’s, Parkinson’s, Neuromuscular, and Other Neurological Diseases
26 Feb 2020 Arcus Biosciences and Taiho Pharmaceutical Co., Ltd. Jointly Announce Taiho’s Exercise of Its Option for an Exclusive License to Zimberelimab (AB122) for Its Territories in Japan and Other Asian Countries
26 Feb 2020 Takeda Acquires PvP Biologics Following Results of a Phase 1 Study of TAK-062 (Kuma062) for the Treatment of Celiac Disease
25 Feb 2020 Peptilogics Announces CARB-X Funding to Accelerate Development of First-in-Class Antibiotics to Address the Global Threat of Multi-drug Resistant Bacteria
25 Feb 2020 Bicycle Therapeutics Announces Exclusive Strategic Collaboration with Genentech to Develop and Commercialize Bicycle®-based Immuno-oncology Therapies
24 Feb 2020 Sanofi to create new industry leading European company to provide active pharmaceutical ingredients (API*)

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2020 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up